FP13.04 KEYNOTE-042 3-Year Survival Update: 1L Pembrolizumab vs Platinum-Based Chemotherapy for PD-L1+ Locally Advanced/Metastatic NSCLC

Byoung Chul Cho, Yi‐Long Wu, G. Lopes, Iveta Kudaba, Dariusz M. Kowalski, H.Z. Turna, Gilberto de Castro, Christian Caglevic, L. Zhang, Bogusława Karaszewska, К. К. Лактионов, Vichien Srimuninnimit, Igor Bondarenko, Kazuo Kubota, L. Yin, J. Lin, Francis Ribeiro de Souza, Tony Mok